The Clinical Role of Euthymia in Mental Health Editorial The Clinical Role of Euthymia in Mental Health Jenny Guidi 1 [1] Department of Psychology ‘Renzo Canestrari’, University of Bologna, Bologna, Italy. Clinical Psychology in Europe, 2024, Vol. 6(2), Article e14349, https://doi.org/10.32872/cpe.14349 Published (VoR): 2024-06-28 Handling Editor: Winfried Rief, Philipps-University of Marburg, Marburg, Germany Corresponding Author: Jenny Guidi, Department of Psychology ‘Renzo Canestrari’, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy. E-mail: jenny.guidi2@unibo.it The concept of euthymia was defined in the psychiatric literature essentially in negative terms, and extensively used to refer to the absence of mood disturbances meeting the threshold for a mental disorder based on diagnostic criteria or on cut-off points of dimensional assessment tools. However, in both unipolar and bipolar mood disorders, psychological distress may fluctuate considerably over time, even during the so-called ‘euthymic’ periods, and residual symptoms appear to be exceedingly common, indicating that the disorder is still present even though its intensity may vary (Dunner, 1999; Fava, 1999; Judd et al., 2002). This, in turn, could negatively impact on vulnerability to relapse in the long term (Fava, 1999). The Concept of Euthymia In 2016, Fava and Bech introduced a novel definition of euthymia, according to specific clinimetric criteria, as a state characterized by the lack of mood disturbances that can be subsumed under diagnostic rubrics and the presence of features such as positive affect and balanced levels in psychological well-being dimensions (namely, autonomy, environmental mastery, positive relations with others, personal growth, purpose in life and self-acceptance), leading to flexibility, consistency, and resistance to stress (i.e., anxiety- or frustration-tolerance and resilience) (Fava & Bech, 2016). These psychological well-being dimensions, that were derived from Marie Jahoda’s model of positive mental health (Jahoda, 1958), have a bipolar nature, ranging from suboptimal to excessively elevated levels, and interact with each other through a compensatory, or eventually dysfunctional, dynamic balance. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License, CC BY 4.0, which permits unrestricted use, distribution, and reproduction, provided the original work is properly cited. https://crossmark.crossref.org/dialog/?doi=10.32872/cpe.14349&domain=pdf&date_stamp=2024-06-28 https://orcid.org/0000-0001-6815-2738 https://www.psychopen.eu/ https://cpe.psychopen.eu/ https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ This unifying concept of euthymia was subsequently refined by Fava and Guidi (2020) and further elaborated (Guidi & Fava, 2020, 2022), with particular regard to its relationships with other clinical constructs (e.g., individual characteristics, concurrent distress and other psychological attributes), and its associations with lifestyle behaviors and allostatic load. Allostatic load can be conceived as a result of the cumulative effects of daily life experiences encompassing both major challenges (i.e., life events) and ordinary events (i.e., subtle and/or repeated sources of chronic stress) (McEwen & Stellar, 1993). When environmental challenges exceed the individual ability to cope, then allostatic overload ensues, with a number of negative consequences on both physical and mental health (Fava et al., 2019; Guidi et al., 2021). According to McEwen’s (2020) viewpoint, ‘euthymia means using allostatis optimally and maintaining a healthy balance that promotes positive aspects of brain and body health through health-promoting be­ haviors’. Such behaviors include not only healthy eating habits, but also adequate and good-quality sleep, regular physical activity, refraining from smoking, alcohol and drug consumption, as well as positive social interactions and features of physical environment, which contribute to reduce allostatic load. Clinical Assessment of Euthymia Exclusive reliance on diagnostic criteria (i.e., DSM-5-TR, ICD-11) often does not allow to capture the complexity of several manifestations that are encountered in clinical practice. A comprehensive clinical assessment requires appropriate collection and integration of a number of clinical variables, according to a clinimetric framework (Fava, 2022). Clinical interviewing should encompass evaluation of euthymia (Guidi & Fava, 2022), allostatic load/overload (Fava et al., 2019; Guidi & Fava, 2022) and lifestyle habits according to a longitudinal perspective. Instruments for assessing euthymia according to clinimetric principles have been developed. The Clinical Interview for Euthymia (CIE; Guidi & Fava, 2022) is a 22-item observer-rated clinimetric tool for gathering information on pos­ itive affect, both impaired and excessive levels in psychological well-being dimensions, flexibility, consistency and resistance to stress. Further, the Semi-Structured Interview for the Diagnostic Criteria for Psychosomatic Research (SSI-DCPR; Guidi & Fava, 2022) permits to assess, among other psychosomatic syndromes, allostatic overload and related constructs, such as demoralization. As to self-rated clinimetric measures, the 10-item Euthymia Scale (ES; Fava & Bech, 2016; Carrozzino et al., 2019) represents an expanded version of the WHO-5 Well-Being Index (WHO-5; Topp et al., 2015) to evaluate positive affect and Jahoda’s well-being dimensions (i.e., flexibility, consistency and resistance to stress). Other clinimetric instru­ ments that may be used jointly are the PsychoSocial Index (PSI; Piolanti et al., 2016) encompassing aspects related to allostatic load, and the Symptom Questionnaire (SQ; Benasi et al., 2020) for assessing both distress symptoms and well-being. Euthymia in Mental Health 2 Clinical Psychology in Europe 2024, Vol. 6(2), Article e14349 https://doi.org/10.32872/cpe.14349 https://www.psychopen.eu/ Euthymia as a Treatment Target Euthymia can be regarded as a therapeutic target, particularly when pre-planned sequen­ tial treatment strategies are implemented (e.g., psychotherapy after pharmacotherapy, or the sequential combination of two psychotherapeutic strategies) to decrease vulnerability to relapse in affective disorders, increase the level of recovery, and modulate mood (Guidi & Fava, 2021). Well-Being Therapy (WBT; Fava, 2016; Guidi & Fava, 2020) is a manualized, short- term psychotherapeutic approach specifically aimed at modulating psychological well- being and pursuing a state of euthymia. WBT has introduced a clinical revolution in self-observation: patients are encouraged to identify episodes of well-being and their situational contexts. This systematic monitoring of well-being by using a structured diary represents a key, distinct therapeutic ingredient of WBT (Fava, 2016; Guidi & Fava, 2020), facilitates interaction between patients and therapists, and stimulates cognitive restructuring and homework (e.g., optimal experiences) based on the individual’s account and material. Psychotherapeutic strategies geared to euthymia, such as WBT, should be applied within a clinimetric framework, based on clinical reasoning and case formulation accord­ ing to macro- and micro-analysis, and staging (Fava, 2022). The treatment plan should be filtered by clinical judgment and integrate a number of clinical variables, such as severity and features of psychiatric disturbances, co-occurring symptoms and problems, medical comorbidities, patient’s history and preferences, and psychological well-being (Fava, 2022). Clinical Applications and New Developments There are several potential clinical applications of treatments that target euthymia, including relapse prevention in depressive disorders, improving recovery in affective and other psychiatric disorders, modulating mood in bipolar-spectrum disorders, managing treatment resistance as well as discontinuation of psychotropic drugs, treating suicidal behavior and post-traumatic stress disorder (Guidi & Fava, 2020). Further, more recent findings support the clinical relevance of euthymia and lifestyle modification in improv­ ing medical outcomes, particularly in the setting of chronic medical diseases (Rafanelli et al., 2020). Indeed, a personalized approach targeting psychological well-being and euthy­ mia may effectively improve patients’ health attitudes and behavior, and promote endur­ ing lifestyle changes (Fava et al., 2023). Potential technical developments of WBT may derive from its application to couples, families, and groups, whereas computerized/digital methods of delivery could also be feasible, yet to be tested. Guidi 3 Clinical Psychology in Europe 2024, Vol. 6(2), Article e14349 https://doi.org/10.32872/cpe.14349 https://www.psychopen.eu/ Conclusions The clinical role of euthymia supports innovative approaches to the assessment and treatment of mental disorders, and provides new, important insights in their psychother­ apeutic management by modifying customary psychiatric approach, still unbalanced towards psychological dysfunction. Funding: The author has no funding to report. Acknowledgments: The author has no additional (i.e., non-financial) support to report. Competing Interests: Prof. Jenny Guidi has no competing interests, financial or otherwise to declare. Related Versions: This Editorial is based on Prof. Jenny Guidi’s oral presentation at the EACLIPT x UMH Conference 2024 in Amsterdam. References Benasi, G., Fava, G. A., & Rafanelli, C. (2020). Kellner’s Symptom Questionnaire, a highly sensitive patient-reported outcome measure: Systematic review of clinimetric properties. Psychotherapy and Psychosomatics, 89(2), 74–89. https://doi.org/10.1159/000506110 Carrozzino, D., Svicher, A., Patierno, C., Berrocal, C., & Cosci, F. (2019). The Euthymia Scale: A clinimetric analysis. Psychotherapy and Psychosomatics, 88(2), 119–121. https://doi.org/10.1159/000496230 Dunner, D. L. (1999). Duration of periods of euthymia in patients with dysthymic disorder. The American Journal of Psychiatry, 156(12), 1992–1993. https://doi.org/10.1176/ajp.156.12.1992 Fava, G. A. (1999). Subclinical symptoms in mood disorders: Pathophysiological and therapeutic implications. Psychological Medicine, 29(1), 47–61. https://doi.org/10.1017/S0033291798007429 Fava, G. A. (2016). Well-being therapy: Treatment manual and clinical applications. Karger. Fava, G. A. (2022). Forty years of clinimetrics. Psychotherapy and Psychosomatics, 91(1), 1–7. https://doi.org/10.1159/000520251 Fava, G. A., & Bech, P. (2016). The concept of euthymia. Psychotherapy and Psychosomatics, 85(1), 1–5. https://doi.org/10.1159/000441244 Fava, G. A., Cosci, F., Sonino, N., & Guidi, J. (2023). Understanding health attitudes and behavior. The American Journal of Medicine, 136(3), 252–259. https://doi.org/10.1016/j.amjmed.2022.10.019 Fava, G. A., & Guidi, J. (2020). The pursuit of euthymia. World Psychiatry, 19(1), 40–50. https://doi.org/10.1002/wps.20698 Fava, G. A., McEwen, B. S., Guidi, J., Gostoli, S., Offidani, E., & Sonino, N. (2019). Clinical characterization of allostatic overload. Psychoneuroendocrinology, 108, 94–101. https://doi.org/10.1016/j.psyneuen.2019.05.028 Euthymia in Mental Health 4 Clinical Psychology in Europe 2024, Vol. 6(2), Article e14349 https://doi.org/10.32872/cpe.14349 https://doi.org/10.1159/000506110 https://doi.org/10.1159/000496230 https://doi.org/10.1176/ajp.156.12.1992 https://doi.org/10.1017/S0033291798007429 https://doi.org/10.1159/000520251 https://doi.org/10.1159/000441244 https://doi.org/10.1016/j.amjmed.2022.10.019 https://doi.org/10.1002/wps.20698 https://doi.org/10.1016/j.psyneuen.2019.05.028 https://www.psychopen.eu/ Guidi, J., & Fava, G. A. (2020). The emerging role of euthymia in psychotherapy research and practice. Clinical Psychology Review, 82, Article 101941. https://doi.org/10.1016/j.cpr.2020.101941 Guidi, J., & Fava, G. A. (2021). Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: A systematic review and meta-analysis. JAMA Psychiatry, 78(3), 261–269. https://doi.org/10.1001/jamapsychiatry.2020.3650 Guidi, J., & Fava, G. A. (2022). The clinical science of euthymia: A conceptual map. Psychotherapy and Psychosomatics, 91(3), 156–167. https://doi.org/10.1159/000524279 Guidi, J., Lucente, M., Sonino, N., & Fava, G. A. (2021). Allostatic load and its impact on health: A systematic review. Psychotherapy and Psychosomatics, 90(1), 11–27. https://doi.org/10.1159/000510696 Jahoda, M. (1958). Current concepts of positive mental health. Basic Books. Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59(6), 530–537. https://doi.org/10.1001/archpsyc.59.6.530 McEwen, B. S. (2020). The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry, 19(1), 57–58. https://doi.org/10.1002/wps.20720 McEwen, B. S., & Stellar, E. (1993). Stress and the individual: Mechanisms leading to disease. Archives of Internal Medicine, 153(18), 2093–2101. https://doi.org/10.1001/archinte.1993.00410180039004 Piolanti, A., Offidani, O., Guidi, J., Gostoli, S., Fava, G. A., & Sonino, N. (2016). Use of the PsychoSocial Index (PSI): A sensitive tool in research and practice. Psychotherapy and Psychosomatics, 85(6), 337–345. https://doi.org/10.1159/000447760 Rafanelli, C., Gostoli, S., Buzzichelli, S., Guidi, J., Sirri, L., Gallo, P., Marzola, E., Bergerone, S., De Ferrari, G. M., Roncuzzi, R., Di Pasquale, G., Abbate-Daga, G., & Fava, G. A. (2020). Sequential combination of cognitive-behavioral treatment and Well-Being Therapy in depressed patients with acute coronary syndromes: A randomized controlled trial (TREATED-ACS Study). Psychotherapy and Psychosomatics, 89(6), 345–356. https://doi.org/10.1159/000510006 Topp, C. W., Østergaard, S. D., Søndergaard, S., & Bech, P. (2015). The WHO-5 Well-Being Index: A systematic review of the literature. Psychotherapy and Psychosomatics, 84(3), 167–176. https://doi.org/10.1159/000376585 Clinical Psychology in Europe (CPE) is the official journal of the European Association of Clinical Psychology and Psychological Treatment (EACLIPT). PsychOpen GOLD is a publishing service by Leibniz Institute for Psychology (ZPID), Germany. Guidi 5 Clinical Psychology in Europe 2024, Vol. 6(2), Article e14349 https://doi.org/10.32872/cpe.14349 https://doi.org/10.1016/j.cpr.2020.101941 https://doi.org/10.1001/jamapsychiatry.2020.3650 https://doi.org/10.1159/000524279 https://doi.org/10.1159/000510696 https://doi.org/10.1001/archpsyc.59.6.530 https://doi.org/10.1002/wps.20720 https://doi.org/10.1001/archinte.1993.00410180039004 https://doi.org/10.1159/000447760 https://doi.org/10.1159/000510006 https://doi.org/10.1159/000376585 https://www.psychopen.eu/ Euthymia in Mental Health (Introduction) The Concept of Euthymia Clinical Assessment of Euthymia Euthymia as a Treatment Target Clinical Applications and New Developments Conclusions (Additional Information) Funding Acknowledgments Competing Interests Related Versions References